Drug Product
Company Overview
About
Lavipharm is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:Greece
Founded:2007
Employees:129
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Global
Manufacturing Facilities
1 site worldwide
Lavipharm S.A.
Agias Marinas Street, P.O. Box 59, Paiania, 19002
Site Capabilities
4 capabilitiesLABEL
PACK
RELABEL
REPACK
International Regulatory
EU GMP Certificates
1
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval TIDCDU
EMA · #APR-H1BA3HO0 · 2020-05-01
Drug Approval DOM9JS
FDA · #APR-98IM21Y9 · 2019-04-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-I2YA8IOJ
Issued: 2020-02-04
Expires: 2025-06-16
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-1P439C8B
Issued: 2020-11-21
Expires: 2025-09-04
WHO GMP
World Health Organization
Cert #: CERT-4DJGNBAW
Issued: 2020-09-19
Expires: 2025-08-12
Health Canada GMP
Health Canada
Cert #: CERT-3FQB0636
Issued: 2020-02-08
Expires: 2025-10-13
Loading CDMO intelligence...
Key facts about Lavipharm
- Lavipharm is headquartered in Greece.
- Lavipharm was founded in 2007.
- Lavipharm has 129 employees.
- Lavipharm has one manufacturing site listed on CDMO Hub, in Paiania, Greece.
- Lavipharm's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Lavipharm
Directory pages this company appears in, each with the full list of matching manufacturers.